HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
5- tert- butyl- 6- chloro- N- (3- iodo- 4- methyl- phenyl)pyrazine- 2- carboxamide
structure in first source
Also Known As:
5-TBC-IMP-PCA cpd
Networked:
1
relevant articles (
0
outcomes,
0
trials/studies)
Bio-Agent Context: Research Results
Heterocyclic Compounds: 198
1-Ring Heterocyclic Compounds
Pyrazines: 150
5-tert-butyl-6-chloro-N-(3-iodo-4-methyl-phenyl)pyrazine-2-carboxamide: 1
Experts
1.
Dolezal, Martin
: 1 article (10/2009)
2.
Kesetovicová, Diana
: 1 article (10/2009)
3.
Kunes, Jirí
: 1 article (10/2009)
4.
Svobodová, Michaela
: 1 article (10/2009)
5.
Zitko, Jan
: 1 article (10/2009)
Related Diseases
1.
Tuberculosis (Tuberculoses)
10/20/2009 - "
tuberculosis (MIC < 2.0 micromol/L), while another iodo derivative 5-tert-butyl-6-chloro-N-(3-iodo-4-methyl-phenyl)pyrazine-2-carboxamide (12) was the most active compound in the TAACF antituberculosis screening program (IC(90) = 0.819 microg/mL).
"